Opportunity Pharma and OpenEye, Cadence Molecular Sciences join forces to power decision-making for drug discovery investors <26 SEPTEMBER 2023> <ALDERLEY PARK, UK> Opportunity Pharma and OpenEye, Cadence Molecular Sciences, have signed an agreement whereby Opportunity Pharma will utilise OpenEye&rs...